Adverse effects: Clinically important general adverse effect (no data) · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Quality of life: No clinically important change in quality of life · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Economic outcomes: Cost of care · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Relapse · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Clinical response: no clinically significant response in mental state · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Behaviour: Leaving the study early (short‐term) · patients with schizophrenia
1 finding from 1 review
Service outcomes: Hospitalisation · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Health service outcomes: 2. Hospital bed‐days by 12 months · patients with schizophrenia
1 finding from 1 review
Adverse effects: Spinal fracture (short‐term) · patients with schizophrenia
ELECTRIC ACUPUNCTURE CONVULSIVE THERAPY may leads to lower adverse effects: Spinal fracture (short‐term) compared with ELECTROCONVULSIVE THERAPY (low certainty).
1 finding from 1 review
Quality of life: No clinically important change in quality of life · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Economic outcomes: Cost of care · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects: Central Nervous System ‐ insomnia (short‐term) · patients with schizophrenia
ACUPUNCTURE added to STANDARD DOSE ANTIPSYCHOTICS may leads to lower adverse effects: Central Nervous System ‐ insomnia (short‐term) compared with STANDARD DOSE ANTIPSYCHOTICS (low certainty).
1 finding from 1 review
Quality of life: No clinically important change in quality of life · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Economic outcomes: Cost of care · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Relapse · patients with schizophrenia
It is very uncertain whether ACUPUNCTURE added to LOW DOSE ANTIPSYCHOTICS changes global state: Relapse ( compared with STANDARD DOSE ANTIPSYCHOTICS (very low certainty).
1 finding from 1 review
Mental state: 2. Not improved (BPRS, < 30% decrease in BPRS score) · patients with schizophrenia
It is very uncertain whether ACUPUNCTURE added to LOW DOSE ANTIPSYCHOTICS changes mental state: BPRS (not improved, reduced rate < 30%, short‐term) compared with STANDARD DOSE ANTIPSYCHOTICS (very low certainty).
1 finding from 1 review
Global state: No clinically important response (as defined by the original studies) · patients with schizophrenia
COMPARISON 1. ARIPIPRAZOLE showed no clear difference in global state: No clinically significant response compared with CLOZAPINE (low certainty).
1 finding from 1 review
Leaving the study early · patients with schizophrenia
It is very uncertain whether COMPARISON 2. ARIPIPRAZOLE changes leaving the study early compared with QUETIAPINE (very low certainty).
1 finding from 1 review
QoL · patients with schizophrenia
1 finding from 1 review
Adverse effects: any observed extrapyramidal symptoms ‐ short term (up to 6 months) · patients with schizophrenia
It is very uncertain whether COMPARISON 2. ARIPIPRAZOLE changes adverse effects: extrapyramidal symptoms compared with QUETIAPINE (very low certainty).
1 finding from 1 review